#BEGIN_DRUGCARD DB01998

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H38O11

# Chemical_IUPAC_Name:
(2R,3S,4R,5R,6S)-2-{[(2S,3R,4R,5S)-3,4-dihydroxy-2-(hydroxymethyl)-5-[(2R)-2-hydroxynonyl]oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol

# HET_ID:
SUM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H38O11/c1-2-3-4-5-6-7-11(23)8-12-15(25)18(28)20(10-22,30-12)31-19-17(27)16(26)14(24)13(9-21)29-19/h11-19,21-28H,2-10H2,1H3/t11-,12+,13+,14+,15+,16-,17+,18-,19-,20+/m1/s1

# InChI_Key:
InChIKey=IMFJFQAURAFEAH-WXZRAZJNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1998

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
454.5091

# Molecular_Weight_Mono:
454.241412058

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1IZ2

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.81

# Predicted_LogS:
-1.5

# Predicted_Water_Solubility:
1.50e+01 g/l

# Primary_Accession_No:
DB01998

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936281

# PubChem_Substance_ID:
46507361

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02980

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCC[C@@H](O)C[C@@H]1O[C@@](CO)(O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:42 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
SERPINA1

# Drug_Target_1_GenBank_ID_Gene:
K01396

# Drug_Target_1_GenBank_ID_Protein:
177829

# Drug_Target_1_GeneCard_ID:
SERPINA1

# Drug_Target_1_Gene_Name:
SERPINA1

# Drug_Target_1_Gene_Sequence:
>1257 bp
ATGCCGTCTTCTGTCTCGTGGGGCATCCTCCTGCTGGCAGGCCTGTGCTGCCTGGTCCCT
GTCTCCCTGGCTGAGGATCCCCAGGGAGATGCTGCCCAGAAGACAGATACATCCCACCAT
GATCAGGATCACCCAACCTTCAACAAGATCACCCCCAACCTGGCTGAGTTCGCCTTCAGC
CTATACCGCCAGCTGGCACACCAGTCCAACAGCACCAATATCTTCTTCTCCCCAGTGAGC
ATCGCTACAGCCTTTGCAATGCTCTCCCTGGGGACCAAGGCTGACACTCACGATGAAATC
CTGGAGGGCCTGAATTTCAACCTCACGGAGATTCCGGAGGCTCAGATCCATGAAGGCTTC
CAGGAACTCCTCCGTACCCTCAACCAGCCAGACAGCCAGCTCCAGCTGACCACCGGCAAT
GGCCTGTTCCTCAGCGAGGGCCTGAAGCTAGTGGATAAGTTTTTGGAGGATGTTAAAAAG
TTGTACCACTCAGAAGCCTTCACTGTCAACTTCGGGGACACCGAAGAGGCCAAGAAACAG
ATCAACGATTACGTGGAGAAGGGTACTCAAGGGAAAATTGTGGATTTGGTCAAGGAGCTT
GACAGAGACACAGTTTTTGCTCTGGTGAATTACATCTTCTTTAAAGGCAAATGGGAGAGA
CCCTTTGAAGTCAAGGACACCGAGGAAGAGGACTTCCACGTGGACCAGGTGACCACCGTG
AAGGTGCCTATGATGAAGCGTTTAGGCATGTTTAACATCCAGCACTGTAAGAAGCTGTCC
AGCTGGGTGCTGCTGATGAAATACCTGGGCAATGCCACCGCCATCTTCTTCCTGCCTGAT
GAGGGGAAACTACAGCACCTGGAAAATGAACTCACCCACGATATCATCACCAAGTTCCTG
GAAAATGAAGACAGAAGGTCTGCCAGCTTACATTTACCCAAACTGTCCATTACTGGAACC
TATGATCTGAAGAGCGTCCTGGGTCAACTGGGCATCACTAAGGTCTTCAGCAATGGGGCT
GACCTCTCCGGGGTCACAGAGGAGGCACCCCTGAAGCTCTCCAAGGCCGTGCATAAGGCT
GTGCTGACCATCGACGAGAAAGGGACTGAAGCTGCTGGGGCCATGTTTTTAGAGGCCATA
CCCATGTCTATCCCCCCCGAGGTCAAGTTCAACAAACCCTTTGTCTTCTTAATGATTGAA
CAAAATACCAAGTCTCCCCTCTTCATGGGAAAAGTGGTGAATCCCACCCAAAAATAA

# Drug_Target_1_General_Function:
Involved in serine-type endopeptidase inhibitor activity

# Drug_Target_1_General_References:
10612848	Seixas S, Garcia O, Amorim A, Rocha J: A novel alpha-1-antitrypsin r281del variant found in a population sample from the Basque country. Hum Mutat. 2000 Jan;15(1):121-2.
10716194	Dunstone MA, Dai W, Whisstock JC, Rossjohn J, Pike RN, Feil SC, Le Bonniec BF, Parker MW, Bottomley SP: Cleaved antitrypsin polymers at atomic resolution. Protein Sci. 2000 Feb;9(2):417-20.
10933492	Elliott PR, Pei XY, Dafforn TR, Lomas DA: Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci. 2000 Jul;9(7):1274-81.
11057674	Huntington JA, Read RJ, Carrell RW: Structure of a serpin-protease complex shows inhibition by deformation. Nature. 2000 Oct 19;407(6806):923-6.
11178897	Kim S, Woo J, Seo EJ, Yu M, Ryu S: A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops. J Mol Biol. 2001 Feb 9;306(1):109-19.
12244055	Im H, Woo MS, Hwang KY, Yu MH: Interactions causing the kinetic trap in serpin protein folding. J Biol Chem. 2002 Nov 29;277(48):46347-54. Epub 2002 Sep 18.
12754519	Zhang H, Li XJ, Martin DB, Aebersold R: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003 Jun;21(6):660-6. Epub 2003 May 18.
12860985	Dementiev A, Simonovic M, Volz K, Gettins PG: Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases. J Biol Chem. 2003 Sep 26;278(39):37881-7. Epub 2003 Jul 14.
1859394	Wu Y, Foreman RC: The molecular genetics of alpha 1 antitrypsin deficiency. Bioessays. 1991 Apr;13(4):163-9.
1905728	Seyama K, Nukiwa T, Takabe K, Takahashi H, Miyake K, Kira S: Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem. 1991 Jul 5;266(19):12627-32.
1967187	Curiel DT, Vogelmeier C, Hubbard RC, Stier LE, Crystal RG: Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele. Mol Cell Biol. 1990 Jan;10(1):47-56.
2035534	Okayama H, Brantly M, Holmes M, Crystal RG: Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet. 1991 Jun;48(6):1154-8.
2227940	Graham A, Kalsheker NA, Bamforth FJ, Newton CR, Markham AF: Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu). Hum Genet. 1990 Oct;85(5):537-40.
2254451	Frazier GC, Siewertsen MA, Hofker MH, Brubacher MG, Cox DW: A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure. J Clin Invest. 1990 Dec;86(6):1878-84.
2309708	Matsunaga E, Shiokawa S, Nakamura H, Maruyama T, Tsuda K, Fukumaki Y: Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan. Am J Hum Genet. 1990 Mar;46(3):602-12.
2316526	Holmes MD, Brantly ML, Curiel DT, Weidinger S, Crystal RG: Characterization of the normal alpha 1-antitrypsin allele Vmunich: a variant associated with a unique protein isoelectric focusing pattern. Am J Hum Genet. 1990 Apr;46(4):810-6.
2339709	Faber JP, Weidinger S, Olek K: Sequence data of the rare deficient alpha 1-antitrypsin variant PI Zaugsburg. Am J Hum Genet. 1990 Jun;46(6):1158-62.
2390072	Holmes MD, Brantly ML, Fells GA, Crystal RG: Alpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant. Biochem Biophys Res Commun. 1990 Aug 16;170(3):1013-20.
2394452	Graham A, Hayes K, Weidinger S, Newton CR, Markham AF, Kalsheker NA: Characterisation of the alpha-1-antitrypsin M3 gene, a normal variant. Hum Genet. 1990 Aug;85(3):381-2.
2606478	Graham A, Kalsheker NA, Newton CR, Bamforth FJ, Powell SJ, Markham AF: Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys). Hum Genet. 1989 Dec;84(1):55-8.
2669992	Kalsheker N: Alpha 1-antitrypsin: structure, function and molecular biology of the gene. Biosci Rep. 1989 Apr;9(2):129-38.
2784123	Hofker MH, Nukiwa T, van Paassen HM, Nelen M, Kramps JA, Klasen EC, Frants RR, Crystal RG: A Pro----Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen. Hum Genet. 1989 Feb;81(3):264-8.
2785270	Engh R, Lobermann H, Schneider M, Wiegand G, Huber R, Laurell CB: The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism. Protein Eng. 1989 Mar;2(6):407-15.
2786335	Fraizer GC, Harrold TR, Hofker MH, Cox DW: In-frame single codon deletion in the Mmalton deficiency allele of alpha 1-antitrypsin. Am J Hum Genet. 1989 Jun;44(6):894-902.
2901226	Nukiwa T, Brantly ML, Ogushi F, Fells GA, Crystal RG: Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele. Am J Hum Genet. 1988 Sep;43(3):322-30.
2985281	Ciliberto G, Dente L, Cortese R: Cell-specific expression of a transfected human alpha 1-antitrypsin gene. Cell. 1985 Jun;41(2):531-40.
3262617	Takahashi H, Nukiwa T, Satoh K, Ogushi F, Brantly M, Fells G, Stier L, Courtney M, Crystal RG: Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida. J Biol Chem. 1988 Oct 25;263(30):15528-34.
3491072	Nukiwa T, Satoh K, Brantly ML, Ogushi F, Fells GA, Courtney M, Crystal RG: Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem. 1986 Dec 5;261(34):15989-94.
3873938	Coutelle C, Speer A, Rogers J, Kalsheker N, Humphries S, Williamson R: Construction and partial characterization of a human liver cDNA library. Biomed Biochim Acta. 1985;44(3):421-31.
3876243	Riley JH, Bathurst IC, Edbrooke MR, Carrell RW, Craig RK: Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver. FEBS Lett. 1985 Sep 23;189(2):361-6.
6093867	Long GL, Chandra T, Woo SL, Davie EW, Kurachi K: Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry. 1984 Oct 9;23(21):4828-37.
6319097	Bollen A, Herzog A, Cravador A, Herion P, Chuchana P, Vander Straten A, Loriau R, Jacobs P, van Elsen A: Cloning and expression in Escherichia coli of full-length complementary DNA coding for human alpha 1-antitrypsin. DNA. 1983;2(4):255-64.
6332197	Loebermann H, Tokuoka R, Deisenhofer J, Huber R: Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531-57.
6387509	Rosenberg S, Barr PJ, Najarian RC, Hallewell RA: Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature. 1984 Nov 1-7;312(5989):77-80.
6604220	Owen MC, Brennan SO, Lewis JH, Carrell RW: Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med. 1983 Sep 22;309(12):694-8.
6979715	Leicht M, Long GL, Chandra T, Kurachi K, Kidd VJ, Mace M Jr, Davie EW, Woo SL: Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes. Nature. 1982 Jun 24;297(5868):655-9.
7031661	Kurachi K, Chandra T, Degen SJ, White TT, Marchioro TL, Woo SL, Davie EW: Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6826-30.
7045697	Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR: Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329-34.
7977369	Faber JP, Poller W, Weidinger S, Kirchgesser M, Schwaab R, Bidlingmaier F, Olek K: Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet. 1994 Dec;55(6):1113-21.
8364590	Hildesheim J, Kinsley G, Bissell M, Pierce J, Brantly M: Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant Pduarte. Hum Mutat. 1993;2(3):221-8.
8543039	Song HK, Lee KN, Kwon KS, Yu MH, Suh SW: Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Lett. 1995 Dec 18;377(2):150-4.
8756325	Elliott PR, Lomas DA, Carrell RW, Abrahams JP: Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol. 1996 Aug;3(8):676-81.
8939743	Ryu SE, Choi HJ, Kwon KS, Lee KN, Yu MH: The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A. Structure. 1996 Oct 15;4(10):1181-92.
9459000	Lovegrove JU, Jeremiah S, Gillett GT, Temple IK, Povey S, Whitehouse DB: A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI Zbristol) associated with novel electrophoretic properties. Ann Hum Genet. 1997 Sep;61(Pt 5):385-91.
9466920	Elliott PR, Abrahams JP, Lomas DA: Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation. J Mol Biol. 1998 Jan 23;275(3):419-25.

# Drug_Target_1_HGNC_ID:
HGNC:8941

# Drug_Target_1_HPRD_ID:
02463

# Drug_Target_1_ID:
1277

# Drug_Target_1_Locus:
14q32.1

# Drug_Target_1_Molecular_Weight:
46737

# Drug_Target_1_Name:
Alpha-1-antitrypsin

# Drug_Target_1_Number_of_Residues:
418

# Drug_Target_1_PDB_ID:
1QLP

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00079	Serpin

# Drug_Target_1_Protein_Sequence:
>Alpha-1-antitrypsin precursor
MPSSVSWGILLLAGLCCLVPVSLAEDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFS
LYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGF
QELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQ
INDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTV
KVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFL
ENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKA
VLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin

# Drug_Target_1_SwissProt_ID:
P01009

# Drug_Target_1_SwissProt_Name:
A1AT_HUMAN

# Drug_Target_1_Synonyms:
Alpha-1 protease inhibitor
Alpha-1- antiproteinase
Alpha-1-antitrypsin precursor

# Drug_Target_1_Theoretical_pI:
5.31

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01998
